Cargando…
Does In Vitro Cytochrome P450 Downregulation Translate to In Vivo Drug‐Drug Interactions? Preclinical and Clinical Studies With 13‐cis‐Retinoic Acid
All‐trans‐retinoic acid (at RA) downregulates cytochrome P450 (CYP)2D6 in several model systems. The aim of this study was to determine whether all active retinoids downregulate CYP2D6 and whether in vitro downregulation translates to in vivo drug–drug interactions (DDIs). The retinoids at RA, 13cis...
Autores principales: | Stevison, Faith, Kosaka, Mika, Kenny, Jane R., Wong, Susan, Hogarth, Cathryn, Amory, John K., Isoherranen, Nina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617839/ https://www.ncbi.nlm.nih.gov/pubmed/30681285 http://dx.doi.org/10.1111/cts.12616 |
Ejemplares similares
-
Determinants of Cytochrome P450 2D6 mRNA Levels in Healthy Human Liver Tissue
por: Ning, Miaoran, et al.
Publicado: (2019) -
Role of cytochrome P450 in drug interactions
por: Bibi, Zakia
Publicado: (2008) -
Effects of Tenapanor on Cytochrome P450‐Mediated Drug‐Drug Interactions
por: Johansson, Susanne, et al.
Publicado: (2017) -
Retraction: Role of cytochrome P450 in drug interactions
por: Bibi, Zakia
Publicado: (2014) -
Cytochrome P450 Enzymes and Drug Metabolism in Humans
por: Zhao, Mingzhe, et al.
Publicado: (2021)